PMC:7441777 / 322-665
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T3 | 288-291 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
| T4 | 302-305 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T4 | 33-41 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T5 | 151-159 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T6 | 278-286 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T7 | 334-342 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 51-52 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T5 | 119-123 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T6 | 199-203 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T7 | 217-221 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T8 | 259-267 | Chemical | denotes | solution | http://purl.obolibrary.org/obo/CHEBI_75958 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 44 | 318-322 | Gene | denotes | RdRp | Gene:43740578 |
| 55 | 33-43 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 77 | 151-159 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 78 | 278-286 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T8 | 93-160 | Sentence | denotes | Currently, no therapeutic drug or vaccine exists to treat COVID-19. |
| T9 | 161-287 | Sentence | denotes | Due to the time taking process of new drug development, drug repurposing might be the only viable solution to tackle COVID-19. |